NEUP Neuphoria Kompaniya foydasi

NEUP (Neuphoria Therapeutics Inc.) - kompaniyaning tovar belgisi

Neuphoria Therapeutics Inc. mustaqil markaziy nerv tizimi (CNS) dori vositalari turkumini ishlab chiqish orqali risklarni minimallashtiradi. Kompaniyaning foyda dinamikasi ushbu jarayonni vizuallashtiradi va qiymat -0.01 darajasida saqlanmoqda. Brendning ilmiy nufuzi xavotir buzilishlari uchun xavfsiz terapiya yaratishga asoslangan. Biroq, tijorat mahsulotlarining yo'qligi kompaniyaning moliyaviy holatini tashqi moliyalashtirish va grantlarga bog'liq qiladi.

Sof daromad: Neuphoria Therapeutics (NEUP) 25.12.2024 - 01.11.2026 uchun

bionomics.com.au (NEUP) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Neuphoria Therapeutics|NEUP - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Neuphoria Therapeutics Inc.|NEUP - Korxona qiymati
- balans kapitallashuvi haqida ma'lumot:
Bitta aksiya hisobiga sof aktivlar qiymati Neuphoria Therapeutics|NEUP - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati bionomics.com.au|NEUP - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Jamlagan qarzning xususiy kapitalga nisbati Neuphoria Therapeutics Inc.|NEUP - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Neuphoria Therapeutics|NEUP - Kompaniya qarzlari|Balans qiymatiga qarzlar Neuphoria Therapeutics Inc.|NEUP - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Neuphoria Therapeutics|Oraliq qoplama koeffitsiyenti bionomics.com.au
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
NEUP - Sof foyda
Kompaniyaning asosiy tahlili:NEUP Neuphoria
Neuphoria Therapeutics, Inc. tovar namunasi

Ushbu ko'rsatkich kunlik sof daromadni hisoblab, choraklik hisobotlarni kutmasdan, joriy kirimlar va xarajatlar o'rtasidagi farqning real vaqt rejimida bahosini taqdim etadi. Miya ion kanallarini modulyatsiyasiga investitsiya kiritayotgan biotexnologik startap Neuphoria Therapeutics Inc. (NEUP) uchun bunday batafsillik mablag'larning sarflanish sur'atlarini (burn rates) baholashda juda muhimdir, bu esa kompaniyaning foyda dinamikasini innovatsion dori vositalarini ishlab chiqish davrida moliyaviy barqarorlikni monitoring qilishning asosiy vositasiga aylantiradi.

Asosiy raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|Kompaniya foydasi RGC (regencellbioscience.com)|Sof foyda AXSM|ACAD - Kompaniyaning sof daromadi|Xenon Pharmaceuticals Inc - Sof daromad|Sof foyda Viking Therapeutics Corp VKTX|SUPN - Kompaniyaning sof foydasi|Soliqdan keyingi foyda CPRX|DNLI: Sof foyda|Harmony Biosciences Inc - Yakuniy foyda|Kompaniyaning sof foydasi Biohaven Pharmaceutical|Kompaniyaning sof daromadi Amylyx Corp AMLX|Kompaniyaning sof foydasi Trevi Therapeutics (TRVI)|PRAX (praxismedicines.com) - Yakuniy foyda|Sof foyda AVXL (Anavex Life Sciences Corp.)|Sof moliyaviy natija CeriBell Inc (CBLL)|Prothena Biosciences - Sof foyda|ALEC - Sof foyda|ANNX (Annexon, Inc.) - Sof daromad|Omeros - Yakuniy foyda|Sof daromad NGNE|ACIU (AC Immune S.A.) - Soliqlar to‘langandan keyingi foyda|Sof foyda VYGR|NMRA (Neumora Corp) - Yakuniy foyda|Sof foyda SCLX (Scilex Holding Company)|tevogen.com (TVGN) - Kompaniyaning sof daromadi|ACOG - Kompaniyaning sof foydasi|Yakuniy foyda CGTX (cogrx.com)|IKT: Sof foyda|Cassava Pharma (SAVA) - Sof foyda|Kompaniyaning sof foydasi Assertio Holdings|Coya - Soliqdan keyingi foyda|Sof foyda VTGN|OVID - Kompaniyaning sof daromadi|Acumen Pharma - Sof daromad|Sof foyda CervoMed Corporation CRVO|ATHE: Sof daromad|Clene Inc. - Soliqlar to‘langandan keyingi foyda|PEPG: Sof foyda|JUNS - Sof moliyaviy natija|RLMD (Relmada) - Sof foyda|Sof daromad Annovis Bio Corporation (ANVS)|Kompaniyaning sof foydasi Grace Therapeutics, Inc. (GRCE)|Sof moliyaviy natija fireflyneuro.com|Klotho Neurosciences - Sof daromad|Yakuniy foyda NRSN|Reviva Pharmaceuticals Holdings - Sof foyda|Sof moliyaviy natija MetaVia Inc MTVA|NeurAxis, Inc. (NRXS) - Kompaniyaning sof foydasi|Kompaniya foydasi HSDT|PASG (Passage Bio Inc.) - Sof foyda|Sof daromad Minerva Neurosciences Inc (NERV)|Sof daromad ATHA (Athira)|Sof moliyaviy natija Addex|Kompaniyaning sof foydasi Alzamend Neuro ALZN|CYCN: Kompaniya foydasi|Protagenic - Sof foyda|Kompaniyaning sof daromadi Pasithea Therapeutics|CRGT (cortigent.com) - Sof daromad|Avenue Therapeutics Inc (ATXI) - Sof foyda|Kompaniyaning sof foydasi Brainstorm Cell|caratherapeutics.com - Soliqdan keyingi foyda|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|eliemtx.com - Kompaniya foydasi|Sof foyda ITCI (Intra-Cellular Therapies, Inc.)|Longboard (LBPH) - Kompaniyaning sof daromadi|MRNS: Sof daromad|NKGN - Sof foyda|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|Sage Therapeutics Inc. - Yakuniy foyda|Kompaniyaning sof foydasi Neurotrope|Kompaniyaning sof daromadi Trevena Inc TRVN|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|Anew Medical Inc. - Kompaniya foydasi|Sof foyda CERE (Cerevel Therapeutics, Inc.)